Highlighted transactions

Healthcare

 

Ellipse Technologies, Inc.

Piper Jaffray served as exclusive financial adviser to Ellipse Technologies, Inc. on its $410 million sale to NuVasive, Inc. Piper Jaffray also served as lead left bookrunner on Ellipse's concurrent S-1 registration statement process.

Client Description

Ellipse is a privately held medical technology company focused on revolutionizing orthopedic surgery by developing and marketing a new generation of non-invasively adjustable orthopedic implant systems. The company's novel and proprietary Magnetic External Control (MAGEC) technology platform enables implants that are adjustable at the time of implantation and non-invasively over the course of treatment to accommodate the changing clinical needs of patients as they heal, grow or age.

Counterparty Description

NuVasive is the third largest medical device company in the global spine industry. NuVasive offers a comprehensive spine portfolio of more than 90 unique products spanning lumbar, thoracic and cervical applications, neuromonitoring services and a biologics portfolio which have been used in hundreds of thousands of spine surgeries.

Back